{"result": "(\"entity\"<|>EMULSIONES LIPÍDICAS<|>ORGANIZATION<|>Emulsiones lipídicas are lipid emulsions used in nutritional support, providing essential fatty acids and calories to patients.)\n##\n(\"entity\"<|>SÍNDROME DE REALIMENTACIÓN<|>EVENT<|>Síndrome de realimentación is a condition that can occur in patients who are being reintroduced to nutrition after a period of malnutrition or starvation, requiring careful management of vitamins and electrolytes.)\n##\n(\"entity\"<|>TIAMINA<|>ORGANIZATION<|>Tiamina, or vitamin B1, is a vitamin that is particularly important for patients at risk of refeeding syndrome.)\n##\n(\"entity\"<|>GUÍAS CLÍNICAS<|>ORGANIZATION<|>Guías clínicas are clinical guidelines that provide recommendations for the management of nutritional support in patients.)\n##\n(\"relationship\"<|>EMULSIONES LIPÍDICAS<|>SOPORTE NUTRICIONAL AVANZADO<|>Emulsiones lipídicas are used in advanced nutritional support to provide essential fatty acids and calories<|>8)\n##\n(\"relationship\"<|>SÍNDROME DE REALIMENTACIÓN<|>SOPORTE NUTRICIONAL AVANZADO<|>Síndrome de realimentación requires specific management in advanced nutritional support<|>6)\n##\n(\"relationship\"<|>TIAMINA<|>SOPORTE NUTRICIONAL AVANZADO<|>Tiamina is a vitamin that needs to be specifically managed in advanced nutritional support for patients at risk of refeeding syndrome<|>7)\n##\n(\"relationship\"<|>GUÍAS CLÍNICAS<|>SOPORTE NUTRICIONAL AVANZADO<|>Guías clínicas provide recommendations for the administration of advanced nutritional support<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: como sales de acetato, fosfato o cloro.\nEl uso de acetato o cloro se adaptará a la situación de los pacientes25:\n\n* En acidosis metabólica: se usarán sales de acetato (como precursor de bicarbonato).\n* En alcalosis metabólica, sales de cloro.\n---\n768      BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\nTabla 1. Requerimientos diarios de electrolitos y minerales19.\n\n| Electrolito/mineral | Requerimientos |\n|---------------------|-----------------|\n| Sodio               | 1-2 mEq/kg/día  |\n| Potasio             | 1-2 mEq/kg/día  |\n| Calcio              | 10-15 mEq /día  |\n| Magnesio            | 8-24 mEg/día    |\n| Fósforo             | 20-40 mmol/día  |\n\nTabla 2. Composición de electrolitos en las secreciones gastrointestinales48 (valores expresados en mEq/l).\n\n| Secreción   | Na      | Cl       | K      | HCO3   |\n|-------------|---------|----------|--------|--------|\n| Gástrica    | 40-100  | 100-140  | 5-10   | 0      |\n| I. delgado  | 100-140 | 100      | 5-20   | 30     |\n| Bilis       | 140     | 100      | 5-10   | 35     |\n| Páncreas    | 140     | 55-75    | 5-10   | 80-120 |\n| Colon       | 25-140  | 20-85    | 35-60  | 30-60  |\n\nCl: cloro; HCO3: bicarbonato; I. delgado: intestino delgado; K: potasio; Na: sodio.\n\nPara un cálculo de los requerimientos de fósforo en la NP, debemos cuantificar el aportado con las emulsiones lipídicas (14-15 mmol de fósforo/l).\n\nSe recomienda añadir calcio y fósforo desde el inicio y ajustar en función de las necesidades25. Las cantidades de calcio y fósforo están limitadas por su solubilidad en la NP, que va a depender del pH de la NP (un pH alcalino favorece la precipitación), del tipo de sal de calcio usada (recomendado el gluconato cálcico) y una ratio calcio/fósforo adecuada (Ca/P: 1/2)45, 46.\n\n5.4. Oligoelementos y vitaminas\n\n5.4.1. Vitaminas\n\nLas vitaminas son compuestos esenciales, ya que el organismo humano es incapaz de sintetizarlas. Sirven de cofactores enzimáticos de una gran variedad de procesos químicos. Los datos sobre los requerimientos de vitaminas intravenosos (IV) son limitados, y van a depender de la situación clínica del paciente. Las recomendaciones diarias IV de vitaminas liposolubles son las mismas que las orales, aunque por vía endovenosa presentan mayor disponibilidad. Esta mayor disponibilidad de vitaminas liposolubles es necesaria debido a un aumento de los requerimientos por la malnutrición, la depleción de las reservas y los cambios metabólicos secundarios a la enfermedad aguda y crónica47.\n\nLa administración de vitaminas hidrosolubles IV, es de 2-5,5 veces superior que la oral. Como en las vitaminas liposolubles, existe un aumento de los requerimientos, pero, además, hay un incremento de la excreción urinaria de estas vitaminas al ser administradas IV48.\n\nLos preparados multivitamínicos para NP aportan vitaminas liposolubles (vitaminas A, D, E, K) e hidrosolubles (B1, B2, B6, niacina, C, ácido fólico, ácido pantoténico y biotina). Existen preparados sin vitamina K.\n\nDebemos tener en cuenta que los pacientes en riesgo de síndrome de realimentación necesitan un aporte específico de vitaminas, fundamentalmente tiamina (vitamina B1)49.\n\n5.4.2. Oligoelementos\n\nDesde que se inició el uso de las soluciones de oligoelementos en la NP a finales de los años 60, estas se han ido modificando. A lo largo de los años, se ha ido disminuyendo el aporte de cobre, manganeso y cromo, e incluyendo selenio en todos los productos a medida que se conocía el efecto de estos oligoelementos en los pacientes con NP.\n\nEn las últimas guías clínicas48, se ajustó la composición de estas soluciones, aumentando el aporte de selenio (requerimientos aumentados en situaciones críticas y enfermedades crónicas50) y reduciendo el aporte de cobre, manganeso y cromo (contaminantes de la NP, pudiendo ser tóxicos en regímen\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ACETATO<|>ORGANIZATION<|>Acetato is a compound used in medical treatments, particularly as a precursor to bicarbonate in metabolic acidosis.)\n##\n(\"entity\"<|>CLORO<|>ORGANIZATION<|>Cloro is a compound used in medical treatments, particularly in metabolic alkalosis.)\n##\n(\"entity\"<|>SOPORTE NUTRICIONAL AVANZADO<|>EVENT<|>Soporte Nutricional Avanzado refers to advanced nutritional support practices in medical settings, including the administration of electrolytes and minerals.)\n##\n(\"entity\"<|>SODIO<|>ORGANIZATION<|>Sodio is an essential electrolyte required in daily nutrition, with specific daily requirements for patients.)\n##\n(\"entity\"<|>POTASIO<|>ORGANIZATION<|>Potasio is an essential electrolyte required in daily nutrition, with specific daily requirements for patients.)\n##\n(\"entity\"<|>CALCIO<|>ORGANIZATION<|>Calcio is an essential mineral required in daily nutrition, with specific daily requirements for patients.)\n##\n(\"entity\"<|>MAGNESIO<|>ORGANIZATION<|>Magnesio is an essential mineral required in daily nutrition, with specific daily requirements for patients.)\n##\n(\"entity\"<|>FOSFORO<|>ORGANIZATION<|>Fósforo is an essential mineral required in daily nutrition, with specific daily requirements for patients.)\n##\n(\"entity\"<|>VITAMINAS<|>ORGANIZATION<|>Vitamins are essential compounds that the human body cannot synthesize and are necessary for various biochemical processes.)\n##\n(\"entity\"<|>OLIGOELEMENTOS<|>ORGANIZATION<|>Oligoelementos are trace elements that are essential for human health and are included in nutritional support solutions.)\n##\n(\"relationship\"<|>ACETATO<|>SOPORTE NUTRICIONAL AVANZADO<|>Acetato is used in advanced nutritional support for patients with metabolic acidosis<|>7)\n##\n(\"relationship\"<|>CLORO<|>SOPORTE NUTRICIONAL AVANZADO<|>Cloro is used in advanced nutritional support for patients with metabolic alkalosis<|>7)\n##\n(\"relationship\"<|>SODIO<|>SOPORTE NUTRICIONAL AVANZADO<|>Sodio is a required electrolyte in advanced nutritional support<|>8)\n##\n(\"relationship\"<|>POTASIO<|>SOPORTE NUTRICIONAL AVANZADO<|>Potasio is a required electrolyte in advanced nutritional support<|>8)\n##\n(\"relationship\"<|>CALCIO<|>SOPORTE NUTRICIONAL AVANZADO<|>Calcio is a required mineral in advanced nutritional support<|>8)\n##\n(\"relationship\"<|>MAGNESIO<|>SOPORTE NUTRICIONAL AVANZADO<|>Magnesio is a required mineral in advanced nutritional support<|>8)\n##\n(\"relationship\"<|>FOSFORO<|>SOPORTE NUTRICIONAL AVANZADO<|>Fósforo is a required mineral in advanced nutritional support<|>8)\n##\n(\"relationship\"<|>VITAMINAS<|>SOPORTE NUTRICIONAL AVANZADO<|>Vitamins are essential components of advanced nutritional support<|>9)\n##\n(\"relationship\"<|>OLIGOELEMENTOS<|>SOPORTE NUTRICIONAL AVANZADO<|>Oligoelementos are included in advanced nutritional support solutions<|>9)\n<|COMPLETE|>"}]}